4.7 Review

Management of Depression in Older Adults A Review

期刊

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
卷 317, 期 20, 页码 2114-2122

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/jama.2017.5706

关键词

-

资金

  1. National Institute of Mental Health (NIMH)
  2. National Institute on Aging (NIA)
  3. National Center for Minority Health Disparities (NIMHD)
  4. National Heart, Lung, and Blood Institute
  5. Centers for Medicare & Medicaid Services (CMS)
  6. Patient-Centered Outcomes Research Institute (PCORI)
  7. Commonwealth of Pennsylvania
  8. John A. Hartford Foundation
  9. Bristol-Myers Squibb
  10. Forest
  11. Pfizer
  12. Lilly
  13. John A Hartford Foundation
  14. National Palliative Care Research Center (NPCRC)
  15. Clinical and Translational Science Institute (CTSI)
  16. American Foundation for Suicide Prevention
  17. National Institutes of Health [P60 MD000207, P30 MH090333, UL1RR024153, UL1TR000005]
  18. UPMC Endowment in Geriatric Psychiatry

向作者/读者索取更多资源

IMPORTANCE Depression in older adults is a common psychiatric disorder affecting their health-related quality of life. Major depression occurs in 2% of adults aged 55 years or older, and its prevalence rises with increasing age. In addition, 10% to 15% of older adults have clinically significant depressive symptoms, even in the absence of major depression. OBSERVATIONS Depression presents with the same symptoms in older adults as it does in younger populations. In contrast to younger patients, older adults with depression more commonly have several concurrent medical disorders and cognitive impairment. Depression occurring in older patients is often undetected or inadequately treated. Antidepressants are the best-studied treatment option, but psychotherapy, exercise therapy, and electroconvulsive therapy may also be effective. Psychotherapy is recommended for patients with mild to moderate severity depression. Many older patients need the same doses of antidepressant medication that are used for younger adult patients. Although antidepressants may effectively treat depression in older adults, they tend to pose greater risk for adverse events because of multiple medical comorbidities and drug-drug interactions in case of polypharmacy. High-quality evidence does not support the use of pharmacologic treatment of depression in patients with dementia. Polypharmacy in older patients can be minimized by using the Screening Tool of Older Persons Prescriptions and Screening Tool to Alert doctors to Right Treatment (STOPP/START) criteria, a valid and reliable screening tool that enables physicians to avoid potentially inappropriate medications, undertreatment, or errors of omissions in older people. Antidepressants can be gradually tapered over a period of several weeks, but discontinuation of antidepressants may be associated with relapse or recurrence of depression, so the patient should be closely observed. CONCLUSIONS AND RELEVANCE Major depression in older adults is common and can be effectively treated with antidepressants and electroconvulsive therapy. Psychological therapies and exercise may also be effective for mild-moderate depression, for patients who prefer nonpharmacological treatment, or for patients who are too frail for drug treatments.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据